FloridaMarijuana.net
AUGUST 15, 2018
Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions. Treatments also seek to increase the subject’s ability to manage trauma-related emotions and to greater confidence in coping abilities. The post Medical Marijuana Offers Hope for Treatment of PTSD appeared first on.
Americans for Safe Access
AUGUST 12, 2024
territories, often serving as a crucial alternative when conventional treatments have failed or as a safer option compared to pharmaceuticals. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., and four of the five U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Life Network
DECEMBER 26, 2021
This upcoming gel might transform cannabis treatments. PreveCeutical, a pharmaceutical company based in Vancouver, recently acquired the rights to commercialize “Sol-Gel” technology. Sol-Gel, developed by a group of researchers at the University of Queensland in Australia, is basically a spray that […].
LifeCannMD
JANUARY 2, 2025
#image_title Medical Marijuana vs. Traditional Pharmaceuticals: A Patient’s Guide to Understanding Your Options When discussing Medical Marijuana for managing chronic pain , Dr. Fernando Fandio-Sende has fielded many questions. Miami patients often ask how it compares to traditional medications they have been taking for years.
Project CBD
OCTOBER 10, 2019
Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Referred to as a “selective CB2 agonist ,” such a compound would appear to have potential as a treatment for scleroderma.
Cannabis Law Report
AUGUST 10, 2021
We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.
The Cannigma
AUGUST 5, 2022
When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment?
Expert insights. Personalized for you.
182 
Let's personalize your content